drugset / Trial / NCT03933072

Autologous Bulbar Olfactory Ensheathing Cells and Nerve Grafts for Treatment of Patients With Spinal Cord Transection

NCT03933072 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this experimental therapy is to evaluate the safety and efficacy of transplantation of autologous olfactory ensheathing cells (OECs) and olfactory nerve fibroblasts (ONFs) obtained from the olfactory bulb with simultaneous reconstruction of the posttraumatic spinal cord gap with peripheral nerve grafts, in patients with chronic complete spinal cord injury. The treatment will be performed in two patients that have sustained an anatomically complete spinal cord transection between the spinal cord segments C5 and Th10. All patients wanting to participate in this study have to send their application at the address: walk-again-project.org

Timeline

Start
2016-03-01
Primary completion
2023-03-01
Completion
2023-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Glial Neuropatch Cell therapy — —

Indications